Roche pushes to catch up to Novo Nordisk's Wegovy with $3.1bn deal for obesity drugmaker Carmot

Upon closing, Roche will obtain all of Berkeley, California-based Carmot’s clinical and pre-clinical assets. The transaction is currently expected …

Continue

Do you trust this headline?

Based on recent headline ratings, 80% of this readership currently trusts the local media, which has an average score of 83% regionally and is currently trending negative.

80%

Media Trust Score80%

Read All

In

News